Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carin L E Hazenberg

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Clinical Oral Investigations|November 5, 2025
Effect of ruxolitinib on the oral mucosa in steroid-refractory graft-versus-host disease: a prospective observational exploratory studyMar Bellido, Ana-Mae E Jonk, Martina Kaurinovic, et al.
Experimental Hematology|December 3, 2014
Erythroid progenitors from patients with low-risk myelodysplastic syndromes are dependent on the surrounding micro environment for their survivalHendrik Folkerts, Carin L E Hazenberg, Ewout J Houwerzijl, et al.
Clinical Oral Investigations|February 16, 2022
Effect of ruxolitinib on the oral mucosa of patients with steroid-refractory chronic Graft-versus-Host disease and oral involvementMartina Kaurinovic, Konstantina Delli, Ana-Mae E Jonk, et al.
Transplantation and Cellular Therapy|May 13, 2024
Improved Outcome of Allogeneic Transplantation in Older Patients Treated for Myeloid Malignancies Using Post-Transplantation Cyclophosphamide and Reduced Duration of Immune SuppressionLinde M Morsink, Carin L E Hazenberg, Goda Choi, et al.
Transplantation and Cellular Therapy|March 30, 2021
Pretransplantation MRD in Older Patients With AML After Treatment With Decitabine or Conventional ChemotherapyJacobien R Hilberink, Linde M Morsink, Walter J F M van der Velden, et al.
The Lancet. Haematology|December 22, 2015
Post-remission treatment with allogeneic stem cell transplantation in patients aged 60 years and older with acute myeloid leukaemia: a time-dependent analysisJurjen Versluis, Carin L E Hazenberg, Jakob R Passweg, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|September 27, 2024
High Frequency of Severe Hyperglycemia Observed During Intensive Hematologic Care: A Prospective Study Using Continuous Glucose MonitoringMarieke Tienstra, Janneke W de Boer, Jaap A van Doesum, et al.
Blood Advances|October 11, 2022
Clonal hematopoiesis in patients with stem cell mobilization failure: a nested case-control studyCarin L E Hazenberg, Aniek O de Graaf, René Mulder, et al.
Bone Marrow Transplantation|September 7, 2023
Allogeneic hematopoietic cell transplantation in patients with CALR-mutated myelofibrosis: a study of the Chronic Malignancies Working Party of EBMTJuan Carlos Hernández-Boluda, Diderik-Jan Eikema, Linda Koster, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Clinical Oral Investigations|November 5, 2025
Effect of ruxolitinib on the oral mucosa in steroid-refractory graft-versus-host disease: a prospective observational exploratory studyMar Bellido, Ana-Mae E Jonk, Martina Kaurinovic, et al.
Experimental Hematology|December 3, 2014
Erythroid progenitors from patients with low-risk myelodysplastic syndromes are dependent on the surrounding micro environment for their survivalHendrik Folkerts, Carin L E Hazenberg, Ewout J Houwerzijl, et al.
Clinical Oral Investigations|February 16, 2022
Effect of ruxolitinib on the oral mucosa of patients with steroid-refractory chronic Graft-versus-Host disease and oral involvementMartina Kaurinovic, Konstantina Delli, Ana-Mae E Jonk, et al.
Transplantation and Cellular Therapy|May 13, 2024
Improved Outcome of Allogeneic Transplantation in Older Patients Treated for Myeloid Malignancies Using Post-Transplantation Cyclophosphamide and Reduced Duration of Immune SuppressionLinde M Morsink, Carin L E Hazenberg, Goda Choi, et al.
Transplantation and Cellular Therapy|March 30, 2021
Pretransplantation MRD in Older Patients With AML After Treatment With Decitabine or Conventional ChemotherapyJacobien R Hilberink, Linde M Morsink, Walter J F M van der Velden, et al.
The Lancet. Haematology|December 22, 2015
Post-remission treatment with allogeneic stem cell transplantation in patients aged 60 years and older with acute myeloid leukaemia: a time-dependent analysisJurjen Versluis, Carin L E Hazenberg, Jakob R Passweg, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|September 27, 2024
High Frequency of Severe Hyperglycemia Observed During Intensive Hematologic Care: A Prospective Study Using Continuous Glucose MonitoringMarieke Tienstra, Janneke W de Boer, Jaap A van Doesum, et al.
Blood Advances|October 11, 2022
Clonal hematopoiesis in patients with stem cell mobilization failure: a nested case-control studyCarin L E Hazenberg, Aniek O de Graaf, René Mulder, et al.
Bone Marrow Transplantation|September 7, 2023
Allogeneic hematopoietic cell transplantation in patients with CALR-mutated myelofibrosis: a study of the Chronic Malignancies Working Party of EBMTJuan Carlos Hernández-Boluda, Diderik-Jan Eikema, Linda Koster, et al.
Pageof 1